Machine learning in cardiovascular medicine: are we there yet?
The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
Artificial intelligence (AI) broadly refers to analytical algorithms that iteratively learn from data, allowing computers to find hidden insights without being explicitly programmed where to look. These include a family of operations encompassing several terms like machine learning, cognitive learning, deep learning and reinforcement learning-based methods that can be used to integrate and interpret complex biomedical and healthcare data in scenarios where traditional statistical methods may not be able to perform. In this review article, we discuss the basics of machine learning algorithms and what potential data sources exist; evaluate the need for machine learning; and examine the potential limitations and challenges of implementing machine in the context of cardiovascular medicine. The most promising avenues for AI in medicine are the development of automated risk prediction algorithms which can be used to guide clinical care; use of unsupervised learning techniques to more precisely phenotype complex disease; and the implementation of reinforcement learning algorithms to intelligently augment healthcare providers. The utility of a machine learning-based predictive model will depend on factors including data heterogeneity, data depth, data breadth, nature of modelling task, choice of machine learning and feature selection algorithms, and orthogonal evidence. A critical understanding of the strength and limitations of various methods and tasks amenable to machine learning is vital. By leveraging the growing corpus of big data in medicine, we detail pathways by which machine learning may facilitate optimal development of patient-specific models for improving diagnoses, intervention and outcome in cardiovascular medicine.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In clinical settings, generalizing the prediction task and building different predictive models by considering contextual variables can minimize the impact of algorithmic bias on clinical decisions”
From SHIFTing artificial intelligence to be responsible in healthcare: a systematic review (2022) · cites this paper as Shameer et al., 2018
Citations
Cites
Machine learning: Trends, perspectives, and prospects
Jordan, M. I., & Mitchell, T. M. (2015) · Science · doi:10.1126/science.aaa8415 · Cited by 9,955 · cited 1×
“17 Additionally, machine learning techniques typically rely on fewer assumptions and provide superior and more robust predictions.”
BackgroundDeep learning in medical image analysis
Shen, D., Wu, G., & Suk, H.-I. (2017) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-071516-044442 · Cited by 4,968
Box, G. E. P. (1976) · Journal of the American Statistical Association · doi:10.1080/01621459.1976.10480949 · Cited by 2,114
Large-scale association analysis identifies new risk loci for coronary artery disease
The CARDIoGRAMplusC4D Consortium, Deloukas, P., DIAGRAM Consortium, CARDIOGENICS Consortium, MuTHER Consortium, Wellcome Trust Case Control Consortium, Kanoni, S., Willenborg, C., Farrall, M., Assimes, T. L., et al. (2013) · Nature Genetics · doi:10.1038/ng.2480 · Cited by 1,614
Machine Learning and Prediction in Medicine — Beyond the Peak of Inflated Expectations
Chen, J. H., & Asch, S. M. (2017) · New England Journal of Medicine · doi:10.1056/nejmp1702071 · Cited by 1,171
Goldstein, B. A., Navar, A. M., Pencina, M. J., & Ioannidis, J. P. A. (2017) · Journal of the American Medical Informatics Association · doi:10.1093/jamia/ocw042 · Cited by 936 · cited 1×
“40 However, machine learning algorithms are not a panacea and also have limitations.”
BackgroundPrediction models for cardiovascular disease risk in the general population: systematic review
Damen, J. A. A. G., Hooft, L., Schuit, E., Debray, T. P. A., Collins, G. S., Tzoulaki, I., Lassale, C. M., Siontis, G. C. M., Chiocchia, V., Roberts, C., et al. (2016) · BMJ · doi:10.1136/bmj.i2416 · Cited by 935
Mendelian randomization of blood lipids for coronary heart disease
Holmes, M. V., Asselbergs, F. W., Palmer, T. M., Drenos, F., Lanktree, M. B., Nelson, C. P., Dale, C. E., Padmanabhan, S., Finan, C., Swerdlow, D. I., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/eht571 · Cited by 748 · cited 1×
“45 MR has recently been used to demonstrate that a biomarker associated with CVD (cystatin C) was not causally related.”
MethodHolmes, M. V., Dale, C. E., Zuccolo, L., Silverwood, R. J., Guo, Y., Ye, Z., Prieto-Merino, D., Dehghan, A., Trompet, S., Wong, A., et al. (2014) · BMJ · doi:10.1136/bmj.g4164 · Cited by 669 · cited 1×
“MR has been used in a number of cardiovascular studies to causally implicate factors like alcohol intake 44 and LDL cholesterol.”
MethodIdentification of type 2 diabetes subgroups through topological analysis of patient similarity
Li, L., Cheng, W.-Y., Glicksberg, B. S., Gottesman, O., Tamler, R., Chen, R., Bottinger, E. P., & Dudley, J. T. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa9364 · Cited by 549
Self-citation
Cited by
Artificial intelligence in cardiology
Johnson, K. W., Torres Soto, J., Glicksberg, B. S., Shameer, K., Miotto, R., Ali, M., Ashley, E., & Dudley, J. T. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.03.521 · Cited by 1,202
Self-citationThe ‘Digital Twin’ to enable the vision of precision cardiology
Corral-Acero, J., Margara, F., Marciniak, M., Rodero, C., Loncaric, F., Feng, Y., Gilbert, A., Fernandes, J. F., Bukhari, H. A., Wajdan, A., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa159 · Cited by 932
“Technical, ethical, and financial constraints limit the data acquisition needed to assist clinical decision-making.(14,15) Synergy between mechanistic and statistical models has shown value in aiding diagnosis, treatment, and prognosis evaluation.”
BackgroundSeyhan, A. A. (2019) · Translational Medicine Communications · doi:10.1186/s41231-019-0050-7 · Cited by 713
Evaluation of artificial intelligence techniques in disease diagnosis and prediction
Ghaffar Nia, N., Kaplanoglu, E., & Nasab, A. (2023) · Discover Artificial Intelligence · doi:10.1007/s44163-023-00049-5 · Cited by 426
State-of-the-Art Deep Learning in Cardiovascular Image Analysis
Litjens, G., Ciompi, F., Wolterink, J. M., de Vos, B. D., Leiner, T., Teuwen, J., & Išgum, I. (2019) · JACC: Cardiovascular Imaging · doi:10.1016/j.jcmg.2019.06.009 · Cited by 388
Metadata
- Authors
- Shameer, K., Johnson, K. W., Glicksberg, B. S., Dudley, J. T., & Sengupta, P. P.
- Affiliations
- Northwell Health (US)
- Mount Sinai Health System (US)
- West Virginia University (US)
- Corresponding author
- Sengupta, Partho P
- Venue
- Heart
- Publisher
- BMJ
- Published
- 2018-01-19
- Volume
- 104
- Issue
- 14
- Pages
- 1156-1164
- ISSN
- 1355-6037 (ISSN-L)
- 1468-201X
- OpenAlex
- W2784094750
- Cited by
- 555
- References
- 49
- Citations by year
- 2026: 57 · 2025: 66 · 2024: 61 · 2023: 61 · 2022: 95 · 2021: 70 · 2020: 73 · 2019: 51 · 2018: 20
- FWCI
- 1.18
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Heart (publishedVersion)
- PubMed (publishedVersion)
- HighWire Press Open Archive (submittedVersion)
- Funders
- National Institutes of Health (UL1TR000067)
- National Cancer Institute (U54CA189201)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK098242)
- National Center for Advancing Translational Sciences
- Topics
- Health Sciences › Medicine › Health Informatics › Artificial Intelligence in Healthcare and Education
- Health Sciences › Health Professions › Health Information Management › Artificial Intelligence in Healthcare
- Physical Sciences › Computer Science › Artificial Intelligence › Machine Learning in Healthcare
- Keywords
- machine learning, artificial intelligence, unsupervised learning, disease phenotyping, reinforcement learning, clinical decision support, big data in healthcare, patient-specific models, data heterogeneity, feature selection
- MeSH terms
- Machine Learning, Big Data, Cardiology, Clinical Trials as Topic, Diagnostic Imaging, Humans, Phenotype, Registries, Causality, Genetic Predisposition to Disease, Genomics, Datasets as Topic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Machine learning in cardiovascular medicine: are we there yet? https://app.cochat.ai/papers/10.1136/heartjnl-2017-311198
- The paper
- Shameer, K., Johnson, K. W., Glicksberg, B. S., Dudley, J. T., & Sengupta, P. P. (2018). Machine learning in cardiovascular medicine: are we there yet? Heart. https://doi.org/10.1136/heartjnl-2017-311198
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.